Research on expression of TIM-3 in AML cells has shown variability in its levels across different cytogenetic subtypes, with t(8;21) and inv(16) being associated with the highest TIM-3 expression [2]. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.